IRI Separation Technologies
2001
FOUNDED
PRIVATE
STATUS
PIPE
LATEST DEAL TYPE
5
FINANCING ROUNDS
1
INVESTMENTS
Description
Provider of biotechnology research services. The company is engaged in the development and extraction of biotechnology products such as monoclonal and polyclonal immunoglobulin antibodies for virus and bacteria related health issues.
Formerly Known As
Immuno Research
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
- 3168 Deer Ridge Drive
- West Vancouver, British Columbia V7S 4W1
- Canada
IRI Separation Technologies Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore IRI Separation Technologies‘s full profile, request access.
Request full access to PitchBookIRI Separation Technologies Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 0000000000 | 06-Nov-2007 | 000000000000000000 | 00.00 | Other Pharmaceuticals and Biotechnology | 0000 00000 |
IRI Separation Technologies Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore IRI Separation Technologies‘s full profile, request access.
Request full access to PitchBook